Cypress Capital Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8M Sell
36,592
-583
-2% -$173K 1.22% 23
2025
Q4
$10.2M Buy
37,175
+1,536
+4% +$417K 1.14% 24
2025
Q3
$9.63M Buy
35,639
+777
+2% +$211K 1.15% 24
2025
Q2
$9.61M Buy
34,862
+726
+2% +$197K 1.2% 22
2025
Q1
$9.06M Buy
34,136
+120
+0.4% +$29.6K 1.19% 22
2024
Q4
$7.9M Sell
34,016
-174
-0.5% -$40K 0.97% 25
2024
Q3
$7.54M Buy
34,190
+373
+1% +$77.2K 0.85% 29
2024
Q2
$6.65M Sell
33,817
-162
-0.5% -$33.5K 0.8% 32
2024
Q1
$7.32M Sell
33,979
-1,729
-5% -$363K 0.88% 27
2023
Q4
$7.52M Buy
35,708
+313
+0.9% +$66.8K 0.98% 25
2023
Q3
$7.09M Buy
35,395
+172
+0.5% +$34.2K 1.02% 24
2023
Q2
$6.53M Sell
35,223
-819
-2% -$151K 0.94% 26
2023
Q1
$6.9M Sell
36,042
-4,796
-12% -$867K 1.06% 22
2022
Q4
$6.87M Sell
40,838
-1,670
-4% -$290K 1.04% 24
2022
Q3
$7.53M Sell
42,508
-3,509
-8% -$693K 1.26% 17
2022
Q2
$9.42M Sell
46,017
-3,039
-6% -$644K 1.43% 11
2022
Q1
$11.7M Buy
49,056
+428
+0.9% +$101K 1.44% 13
2021
Q4
$11.1M Sell
48,628
-3,036
-6% -$668K 1.39% 16
2021
Q3
$9.99M Buy
51,664
+228
+0.4% +$46.2K 1.36% 16
2021
Q2
$10.9M Buy
51,436
+832
+2% +$176K 1.48% 16
2021
Q1
$10.3M Sell
50,604
-822
-2% -$162K 1.47% 15
2020
Q4
$9.36M Sell
51,426
-1,058
-2% -$180K 1.41% 18
2020
Q3
$8.78M Sell
52,484
-5,788
-10% -$975K 1.46% 16
2020
Q2
$9.47M Sell
58,272
-1,530
-3% -$274K 1.74% 12
2020
Q1
$10.3M Sell
59,802
-2,706
-4% -$539K 2.39% 7
2019
Q4
$12.5M Buy
62,508
+622
+1% +$128K 2.23% 5
2019
Q3
$13.1M Sell
61,886
-988
-2% -$206K 2.52% 4
2019
Q2
$12.2M Buy
62,874
+325
+0.5% +$59.9K 2.41% 4
2019
Q1
$10.3M Sell
62,549
-396
-0.6% -$70K 2.11% 7
2018
Q4
$11.8M Sell
62,945
-633
-1% -$117K 2.71% 4
2018
Q3
$10.8M Buy
63,578
+684
+1% +$115K 2.05% 6
2018
Q2
$10.3M Sell
62,894
-163
-0.3% -$26.6K 2.13% 6
2018
Q1
$10.2M Sell
63,057
-105
-0.2% -$16.7K 2.14% 7
2017
Q4
$9.22M Sell
63,162
-945
-1% -$135K 1.92% 7
2017
Q3
$8.7M Buy
64,107
+645
+1% +$81.5K 1.85% 8
2017
Q2
$7.95M Sell
63,462
-1,234
-2% -$148K 1.76% 12
2017
Q1
$7.69M Sell
64,696
-1,423
-2% -$171K 1.8% 13
2016
Q4
$7.63M Sell
66,119
-695
-1% -$77.3K 1.81% 14
2016
Q3
$6.98M Buy
66,814
+265
+0.4% +$27.7K 1.67% 17
2016
Q2
$6.48M Buy
66,549
+771
+1% +$72.9K 1.52% 21
2016
Q1
$6.32M Buy
65,778
+688
+1% +$62.6K 1.55% 19
2015
Q4
$5.9M Buy
65,090
+877
+1% +$82.5K 1.42% 22
2015
Q3
$5.96M Sell
64,213
-395
-0.6% -$37.5K 1.47% 21
2015
Q2
$6.01M Buy
64,608
+1,540
+2% +$144K 1.38% 26
2015
Q1
$5.97M Buy
63,068
+16,440
+35% +$1.52M 1.36% 24
2014
Q4
$4.13M Buy
46,628
+7,271
+18% +$616K 0.96% 38
2014
Q3
$3.15M Buy
39,357
+4,212
+12% +$317K 0.75% 48
2014
Q2
$2.49M Buy
+35,145
New +$2.47M 0.58% 59

Other funds holding CME

Cypress Capital Group's CME Position: Q1 2026 in Review

Cypress Capital Group reduced its CME Group (CME) stake by 1.6% in Q1 2026, selling an estimated $173K and leaving 36,592 shares worth $10.8M. The position accounts for 1.22% of the portfolio, ranked #23.

Cypress Capital Group first reported a position in CME in Q2 2014 and has held it in 48 quarters since. The position peaked at $13.1M in Q3 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Cypress Capital Group held 36,592 shares of CME Group worth $10.8M as of Q1 2026.
  • Cypress Capital Group sold 583 CME Group shares in Q1 2026, an estimated $173K.
  • CME Group made up 1.22% of Cypress Capital Group's portfolio in Q1 2026, its #23 holding.
  • Cypress Capital Group first reported a position in CME Group in Q2 2014 and has held it in 48 quarters since.
  • Cypress Capital Group's CME Group position peaked at $13.1M in Q3 2019.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Cypress Capital Group's 13F filing for Q1 2026, filed 15 May 2026.